Start for free
Start for free
Bluebird Ventures logo

Bluebird Ventures

North America, California, United States, Palo Alto

Description

Bluebird Ventures is an early-stage Life Sciences venture fund.

Investor Profile

Bluebird Ventures has made 11 investments, with 1 in the past 12 months and 18% as lead.

Stage Focus

  • Series B (45%)
  • Series A (27%)
  • Series E (9%)
  • Series D (9%)
  • Series C (9%)

Country Focus

  • United States (91%)
  • The Netherlands (9%)

Industry Focus

  • Health Care
  • Biotechnology
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bluebird Ventures frequently co-invest with?

Amplo
Amplo
North America, Texas, United States, Spring
Co-Investments: 2
Narya Capital
Narya Capital
North America, Ohio, United States, Columbus
Co-Investments: 3
Pear VC
Pear VC
North America, California, United States, Menlo Park
Co-Investments: 3
Civilization Ventures
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 3
JDRF T1D Fund
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3
Foresite Capital
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 5
TC
Transhuman Capital
North America, Michigan, United States, Ann Arbor
Co-Investments: 3
QVT Financial
QVT Financial
North America, New York, United States, New York
Co-Investments: 3
Dexcel Pharma
Dexcel Pharma
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 3
Alumni Ventures
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2

Which angels does Bluebird Ventures often collaborate with?

PM
Paul Manning
North America, Virginia, United States, Charlottesville
Shared Deals: 1
BB
Brook Byers
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Bluebird Ventures?

Foresight Diagnostics

Denver, Colorado, United States

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

BiotechnologyHealth CarePharmaceutical
Series BJul 30, 2024
Amount Raised: $33,000,000
Procyrion

Houston, Texas, United States

Procyrion develops technology solutions and offers a catheter-based circulatory support technologies.

Health CareMedicalMedical Device
Series EFeb 5, 2024
Amount Raised: $47,700,000
Foresight Diagnostics

Denver, Colorado, United States

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

BiotechnologyHealth CarePharmaceutical
Series BApr 27, 2023
Amount Raised: $58,750,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series CMay 16, 2022
Amount Raised: $270,000,000
Leyden Labs

Amsterdam, Noord-Holland, The Netherlands

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

BiotechnologyLife ScienceTherapeutics
Series BJan 25, 2022
Amount Raised: $140,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series BJul 14, 2021
Amount Raised: $100,000,000
Foresight Diagnostics

Denver, Colorado, United States

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

BiotechnologyHealth CarePharmaceutical
Series AJun 2, 2021
Amount Raised: $12,500,000
Nutcracker Therapeutics

Emeryville, California, United States

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BSep 23, 2020
Amount Raised: $60,000,000
Kriya Therapeutics

Palo Alto, California, United States

Kriya Therapeutics is a biopharmaceutical company that develops gene therapies for ophthalmology, neurology, and metabolic diseases.

BiotechnologyHealth CareLife Science
Series AMay 12, 2020
Amount Raised: $80,500,000
Epirium Bio

San Diego, California, United States

Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.

BiopharmaBiotechnologyHealth CareTherapeutics
Series ADec 18, 2019
Amount Raised: $85,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator